Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1820269

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1820269

Bifurcation Lesions Market Report by Types (One-Stent, Two-Stent), Application (Coronary Vascular, Peripheral Vascular), and Region 2025-2033

PUBLISHED:
PAGES: 139 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2999
PDF & Excel (5 User License)
USD 3999
PDF & Excel (Corporate License)
USD 4999

Add to Cart

The global bifurcation lesions market size reached USD 2.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.8 Billion by 2033, exhibiting a growth rate (CAGR) of 4.4% during 2025-2033.

A bifurcation lesion refers to the narrowing of the coronary artery adjacent to the origin of a significant side branch (SB). It is prone to develop atherosclerotic plaque due to turbulent blood flow and high shear stress. It is treated using techniques like analysis, procedure duration, X-ray exposure, and long-term follow-up. Moreover, three-dimensional (3D) angiography and multi-slice computed tomography are utilized for measuring the bifurcation angles. With the advances in devices, imaging, adjunctive pharmacotherapy, and vascular access, the management of complex cases of bifurcation lesions is becoming possible worldwide.

Bifurcation Lesions Market Trends:

A significant rise in the occurrence of coronary artery disease (CAD) is increasing the risk of developing bifurcation lesions. This represents one of the key factors bolstering the market growth. Besides this, the approval of innovative devices, increasing insurance coverage, and improving imaging modalities are also strengthening the market growth. Moreover, the rising geriatric population, which is more likely to develop medical ailments, along with supportive initiatives undertaken by governments of various countries for reimbursement, is supporting the market growth. The increasing medical tourism, the escalating demand for minimally invasive (MI) procedures and the improving healthcare infrastructure are some of the other factors contributing to the growth of the market. Apart from this, the ongoing research on novel treatment techniques is driving the market. For instance, researchers are studying the effectiveness of the Szabo 2-stent technique for complex bifurcations lesions with high compromise risk or fatal consequences of SB occlusion. Furthermore, a wide range of clinical trials on stents and balloons, in confluence with the increasing number of skilled healthcare professionals, is anticipated to decrease risks associated with bifurcation lesions treatment and influence the market positively.

Key Market Segmentation:

Breakup by Types:

  • One-Stent
  • Two-Stent

Breakup by Application:

  • Coronary Vascular
  • Peripheral Vascular

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, Cardinal Health, Medtronic plc, Spectranetics (Koninklijke Philips N.V.) and Terumo Corporation.

Key Questions Answered in This Report

  • 1.What was the size of the global bifurcation lesions market in 2024?
  • 2.What is the expected growth rate of the global bifurcation lesions market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global bifurcation lesions market?
  • 4.What are the key factors driving the global bifurcation lesions market?
  • 5.What is the breakup of the global bifurcation lesions market based on the application?
  • 6.What are the key regions in the global bifurcation lesions market?
  • 7.Who are the key players/companies in the global bifurcation lesions market?
Product Code: SR112025A4003

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bifurcation Lesions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Types

  • 6.1 One-Stent
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Two-Stent
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Coronary Vascular
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Peripheral Vascular
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Boston Scientific Corporation
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Cardinal Health
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Medtronic plc
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Spectranetics (Koninklijke Philips N.V.)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Terumo Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
Product Code: SR112025A4003

List of Figures

  • Figure 1: Global: Bifurcation Lesions Market: Major Drivers and Challenges
  • Figure 2: Global: Bifurcation Lesions Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Bifurcation Lesions Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Bifurcation Lesions Market: Breakup by Types (in %), 2024
  • Figure 5: Global: Bifurcation Lesions Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Bifurcation Lesions Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Bifurcation Lesions (One-Stent) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Bifurcation Lesions (One-Stent) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Bifurcation Lesions (Two-Stent) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Bifurcation Lesions (Two-Stent) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Bifurcation Lesions (Coronary Vascular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Bifurcation Lesions (Coronary Vascular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Bifurcation Lesions (Peripheral Vascular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Bifurcation Lesions (Peripheral Vascular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: North America: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: North America: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: United States: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: United States: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Canada: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Canada: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Asia-Pacific: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Asia-Pacific: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: China: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: China: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Japan: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Japan: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: India: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: India: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: South Korea: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: South Korea: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Australia: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Australia: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Indonesia: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Indonesia: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Others: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Europe: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Europe: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Germany: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Germany: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: France: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: France: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: United Kingdom: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: United Kingdom: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Italy: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Italy: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Spain: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Spain: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Russia: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Russia: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Others: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Latin America: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Latin America: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Brazil: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Brazil: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Mexico: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Mexico: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Middle East and Africa: Bifurcation Lesions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Middle East and Africa: Bifurcation Lesions Market: Breakup by Country (in %), 2024
  • Figure 63: Middle East and Africa: Bifurcation Lesions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Global: Bifurcation Lesions Industry: SWOT Analysis
  • Figure 65: Global: Bifurcation Lesions Industry: Value Chain Analysis
  • Figure 66: Global: Bifurcation Lesions Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bifurcation Lesions Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Bifurcation Lesions Market Forecast: Breakup by Types (in Million USD), 2025-2033
  • Table 3: Global: Bifurcation Lesions Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Bifurcation Lesions Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Bifurcation Lesions Market: Competitive Structure
  • Table 6: Global: Bifurcation Lesions Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!